70 related articles for article (PubMed ID: 24556601)
1. The biology of interleukin-6 in the 21st century.
Rose-John S
Semin Immunol; 2014 Feb; 26(1):1. PubMed ID: 24556601
[No Abstract] [Full Text] [Related]
2. Interleukin-6: an antagonizing problem becomes a solution.
Rettig MB
Nat Biotechnol; 1997 Oct; 15(10):952-3. PubMed ID: 9335041
[No Abstract] [Full Text] [Related]
3. Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
Nakamura I; Omata Y; Naito M; Ito K
J Rheumatol; 2009 Feb; 36(2):459-60. PubMed ID: 19208585
[No Abstract] [Full Text] [Related]
4. Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer.
Weidle UH; Klostermann S; Eggle D; Krüger A
Cancer Genomics Proteomics; 2010; 7(6):287-302. PubMed ID: 21156962
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of IL-6 blockade in rheumatic diseases - implications on IL-6 biology and disease pathogenesis.
Davies R; Choy E
Semin Immunol; 2014 Feb; 26(1):97-104. PubMed ID: 24389239
[TBL] [Abstract][Full Text] [Related]
6. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
7. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.
Yoshizaki K; Nishimoto N; Mihara M; Kishimoto T
Springer Semin Immunopathol; 1998; 20(1-2):247-59. PubMed ID: 9836380
[No Abstract] [Full Text] [Related]
8. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 receptor shedding: a possible role for members of the ADAM family.
Croucher PI; Wang F; Hargreaves PG
Biochem Soc Trans; 1999 Feb; 27(2):224-8. PubMed ID: 10093738
[No Abstract] [Full Text] [Related]
10. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
11. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
12. The IL-6 feed-forward loop: a driver of tumorigenesis.
Chang Q; Daly L; Bromberg J
Semin Immunol; 2014 Feb; 26(1):48-53. PubMed ID: 24613573
[TBL] [Abstract][Full Text] [Related]
13. Historical overview of the interleukin-6 family cytokine.
Kang S; Narazaki M; Metwally H; Kishimoto T
J Exp Med; 2020 May; 217(5):. PubMed ID: 32267936
[TBL] [Abstract][Full Text] [Related]
14. [Interleukin-6 in pathogenesis of rheumatoid arthritis].
Mihara M; Nishimoto N
Nihon Rinsho; 2005 Jan; 63 Suppl 1():158-62. PubMed ID: 15799337
[No Abstract] [Full Text] [Related]
15. [Inflammatory bowel disease: anti-TNF strategies and beyond].
Hoffmann JC
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S76-8. PubMed ID: 15368175
[No Abstract] [Full Text] [Related]
16. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S
Am J Pathol; 2007 Jun; 170(6):2149-58. PubMed ID: 17525280
[TBL] [Abstract][Full Text] [Related]
17. Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells.
Hsu CP; Chen YL; Huang CC; Chou CC; Liu CL; Hung CH; Kao TY; Chung YC
Eur J Clin Invest; 2011 Mar; 41(3):277-84. PubMed ID: 21114487
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
[TBL] [Abstract][Full Text] [Related]
20. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
